Enterprise Sales Executive

Adam Cox

15 years closing six and seven-figure deals in healthcare supply chain and life sciences. Now bringing that track record to the companies shaping AI.

116%
Avg. Quota Attainment
7x
President's Club
202%
Peak Year (2024)

Nine years. Four promotions.

2016 — Present
Strategic Account Executive · 4 promotions
Global Healthcare Exchange (GHX)
Nine years selling cloud-based supply chain platforms to medical device manufacturers, pharmaceutical suppliers, and biotechnology companies across healthcare's largest trading network. The work stayed consistent: complex accounts, multiple stakeholders, C-suite relationships across supply chain, finance, and IT. The quotas just got bigger with each promotion. Averaged 116% across nine years. Peak of 202% in 2024. Named Salesperson of the Year.
2010 -- 2016
Enterprise Account Executive
Quadient
Built and managed a Colorado territory selling enterprise logistics and document software solutions. Ranked top 25% nationally, #2 in new account revenue for consecutive years (2013–2014), and grew territory 46% year-over-year through disciplined account management and consultative selling. Earned 2015 Top Performer, Colorado Region.

What I deliver

The Modernization Sale
The sale isn't the software. It's convincing a complex organization that what they've built around their current systems costs more than replacing them. That's the conversation I've been having for 15 years.
Consultative Discovery
Diagnosing what an organization actually needs before talking product. Working across IT, supply chain, and finance to get everyone pointing the same direction. That's what closes enterprise deals.
Selling the Network
GHX connects 1.3M+ trading partners. I don't sell software, I sell what happens when an organization is plugged into that network. It's a different conversation than a feature demo.
Business Case Development
Translating data from $128B+ in annual transaction volume into business cases that move executives from curiosity to commitment.
Key Verticals
Medical Device Manufacturers Pharmaceutical Suppliers Biotechnology Companies
116%
Average quota attainment across tenure
202%
Peak performance, 2024
4x
Promoted at GHX in nine years
7x
President's Club qualifier
$128B+
Annual transaction volume across the GHX network

How I sell

I ask better questions than anyone in the room.
Understanding the real problem, not the stated one, is where deals actually begin. Curiosity is the skill that doesn't show up on a quota report.
I know where the whitespace is.
Every hour I spend with a prospect is deliberate. I don't chase what doesn't fit. Knowing what to walk away from is as important as knowing what to pursue. That's what makes 116% look repeatable.
Numbers cut through noise.
First call or QBR, every conversation runs on the customer's own numbers. Abstract value propositions don't close enterprise deals. Quantified ROI does.
Closed-won is the beginning, not the end.
My highest-value relationships started as renewals that turned into multi-year expansions. I sell with the end in mind because that's where the real revenue is.

Why AI. Why now.

For 15 years, I've watched the industry with the highest stakes move slower than almost any other on technology adoption. The reasons aren't hard to understand: regulation, risk aversion, genuine fear of getting it wrong. But staying put has costs too. AI is the first thing I've seen that can actually shift that.

I've spent my career selling platforms where massive data flows meet operations that can't afford to fail. The companies building AI for the enterprise need sellers who know that territory. People who can walk into a room of skeptical VPs and make the abstract feel inevitable.

I'm already operating this way. I use AI to run tailored outreach at scale, build executive-ready presentations faster than my competitors expect, and find the right opportunities before they know they exist. This isn't where I'm headed. It's how I already work.

For 15 years, the ROI conversation in healthcare was about cost and friction. AI — built responsibly — is the first technology where it can genuinely be about outcomes: a drug that reaches patients faster, a diagnosis that doesn't get missed, access to care that didn't exist before. That's what I want to spend the next chapter selling.

Awards

Salesperson of the Year GHX · 2019
Strategic Account Manager of the Year GHX · 2024
Division Sales Rep of the Year GHX · 3x
Mid-Market Sales Rep of the Year GHX · 2x
President's Club GHX · 7x

Let's talk.

The team bringing AI into healthcare and life sciences needs someone who already speaks the language. I've spent the last decade in that room. Let's talk about what that looks like on your team.